For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240723:nRSW4664Xa&default-theme=true
RNS Number : 4664X Inspiration Healthcare Group PLC 23 July 2024
23 July 2024
Inspiration Healthcare Group plc
("Inspiration Healthcare", the "Company" or the "Group")
Director / PDMR Dealing
Inspiration Healthcare Group plc (AIM: IHC), the global medical technology
company, announces that Neil Campbell, Non-Executive Director, has gifted a
total of 71,428 ordinary shares of 10 pence each in the capital of the Company
("Ordinary Shares") to his children, Oliver Campbell and Edward Campbell, for
nil consideration. This is in accordance with Neil Campbell's intention, as
stated in the Company's Result of Placing and Subscription announcement on 26
June 2024.
The 71,428 Ordinary Shares are being gifted equally, with 35,714 Ordinary
Shares to Oliver Campbell and 35,714 Ordinary Shares to Edward Campbell.
Oliver and Edward Campbell are both PCAs of Neil Campbell.
Following the transfer, Neil Campbell holds 4,416,646 Ordinary Shares
representing approximately 4.93% of the Company's issued share capital, Oliver
Campbell holds 43,330 Ordinary Shares representing approximately 0.05% of the
Company's issued share capital, and Edward Campbell holds 35,714 Ordinary
Shares representing approximately 0.04% of the Company's issued share capital.
The information below, set out in accordance with the requirements of the UK
Market Abuse Regulation, provides further detail on the shares gifted.
For further information:
Inspiration Healthcare Group plc Tel: +44 (0)330
175 0000
Roy Davis, Executive Chair and Interim CEO
Alan Olby, Chief Financial Officer
Liberum (Nominated Adviser & Broker) Tel: +44 (0)20
3100 2000
Richard Lindley, Will King, Joshua Borlant
Walbrook PR Ltd (Media and Investor Relations) Tel: +44 (0)20
7933 8700 or inspirationhealthcare@walbrookpr.com
(mailto:inspirationhealthcare@walbrookpr.com)
Anna Dunphy, Stephanie Cuthbert, Louis Ashe-Jepson
NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING
MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Neil Campbell
2 Reason for the notification
a) Position/status PDMR - Non-Executive Director
b) Initial notification /Amendment Initial
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Inspiration Healthcare Group plc
b) LEI 213800GKFT3ENAPMDL15
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of 10p each in the capital of the Company
Identification code ISIN: GB00BXDZL105
b) Nature of the transaction Gift of shares to his children
c) Price(s) and volume(s)
Price(s) Volume(s)
Nil 71,428
d) Aggregated information
- Aggregated volume
N/A - single transaction
- Price
e) Date of the transaction 23 July 2024
f) Place of the transaction Outside of a trading venue
d)
Aggregated information
- Aggregated volume
- Price
N/A - single transaction
e)
Date of the transaction
23 July 2024
f)
Place of the transaction
Outside of a trading venue
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Oliver Campbell
2 Reason for the notification
a) Position/status PCA of Neil Campbell, Non-Executive Director
b) Initial notification /Amendment Initial
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Inspiration Healthcare Group plc
b) LEI 213800GKFT3ENAPMDL15
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of 10p each in the capital of the Company
Identification code ISIN: GB00BXDZL105
b) Nature of the transaction Receipt of shares from Neil Campbell
c) Price(s) and volume(s)
Price(s) Volume(s)
Nil 35,714
d) Aggregated information
- Aggregated volume
N/A - single transaction
- Price
e) Date of the transaction 23 July 2024
f) Place of the transaction Outside of a trading venue
d)
Aggregated information
- Aggregated volume
- Price
N/A - single transaction
e)
Date of the transaction
23 July 2024
f)
Place of the transaction
Outside of a trading venue
1 Details of the person discharging managerial responsibilities / person closely
associated
a) Name Edward Campbell
2 Reason for the notification
a) Position/status PCA of Neil Campbell, Non-Executive Director
b) Initial notification /Amendment Initial
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
a) Name Inspiration Healthcare Group plc
b) LEI 213800GKFT3ENAPMDL15
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
a) Description of the financial instrument, type of instrument Ordinary Shares of 10p each in the capital of the Company
Identification code ISIN: GB00BXDZL105
b) Nature of the transaction Receipt of shares from Neil Campbell
c) Price(s) and volume(s)
Price(s) Volume(s)
Nil 35,714
d) Aggregated information
- Aggregated volume
N/A - single transaction
- Price
e) Date of the transaction 23 July 2024
f) Place of the transaction Outside of a trading venue
d)
Aggregated information
- Aggregated volume
- Price
N/A - single transaction
e)
Date of the transaction
23 July 2024
f)
Place of the transaction
Outside of a trading venue
About Inspiration Healthcare Group plc
Inspiration Healthcare (AIM: IHC) designs, manufactures and markets pioneering
medical technology. Based in the UK, the Company specialises in neonatal
intensive care medical devices, which are addressing a critical need to help
to save the lives and improve the outcomes of patients, starting with the very
first breaths of life.
The Company has a broad portfolio of its own products and complementary
distributed products, for use in neonatal intensive care designed to support
even the most premature babies throughout their hospital stay. Its own branded
products range from highly sophisticated capital equipment such as ventilators
for life support through to single-use disposables.
The Company sells its products directly to hospitals and healthcare providers
in the UK and Ireland, where it also distributes a range of advanced medical
technologies for infusion therapy. In the rest of the world the Company has
an established network of distribution partners around the world giving access
to more than 75 countries.
The Company operates in the UK from its world-class Manufacturing and
Technology Centre in Croydon, South London and in the USA from its facility in
Melbourne, Florida.
Further information on Inspiration Healthcare can be found at
www.inspirationhealthcaregroup.com (http://www.inspirationhealthcaregroup.com)
.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHFIFVTDRIVFIS